no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adjuvants and inactivated polio vaccine: A systematic review
|
Hawken, Jennifer |
|
2012 |
30 |
49 |
p. 6971-6979 9 p. |
article |
2 |
Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak
|
Abedi, Glen R. |
|
2012 |
30 |
49 |
p. 7052-7058 7 p. |
article |
3 |
A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children
|
Seale, Holly |
|
2012 |
30 |
49 |
p. 7027-7031 5 p. |
article |
4 |
Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review
|
Isai, Alina |
|
2012 |
30 |
49 |
p. 7123-7129 7 p. |
article |
5 |
A Vaxfectin®-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes
|
Veselenak, Ronald L. |
|
2012 |
30 |
49 |
p. 7046-7051 6 p. |
article |
6 |
Childhood immunization reporting laws in the United States: Current status
|
Hedden, Erika M. |
|
2012 |
30 |
49 |
p. 7059-7066 8 p. |
article |
7 |
Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach
|
Kirk, K. |
|
2012 |
30 |
49 |
p. 7105-7110 6 p. |
article |
8 |
Early infection dynamics after experimental challenge with Mycobacterium avium subspecies paratuberculosis in calves reveal limited calf-to-calf transmission and no impact of Hsp70 vaccination
|
Santema, Wiebren J. |
|
2012 |
30 |
49 |
p. 7032-7039 8 p. |
article |
9 |
Editorial Board/Aims and Scope
|
|
|
2012 |
30 |
49 |
p. CO2- 1 p. |
article |
10 |
Efficacy of Hyalomma scupense (Hd86) antigen against Hyalomma excavatum and H. scupense tick infestations in cattle
|
Galaï, Yousr |
|
2012 |
30 |
49 |
p. 7084-7089 6 p. |
article |
11 |
Establishment of a Shigella sonnei human challenge model in Thailand
|
Bodhidatta, Ladaporn |
|
2012 |
30 |
49 |
p. 7040-7045 6 p. |
article |
12 |
Heteroclitic peptides enhance human immunodeficiency virus-specific CD8+ T cell responses
|
Gladney, Krista H. |
|
2012 |
30 |
49 |
p. 6997-7004 8 p. |
article |
13 |
Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake
|
Donadiki, Elisavet M. |
|
2012 |
30 |
49 |
p. 6967-6970 4 p. |
article |
14 |
Immune response after one or two doses of pandemic influenza A (H1N1) monovalent, AS03-adjuvanted vaccine in HIV infected adults
|
Nielsen, Allan Bybeck |
|
2012 |
30 |
49 |
p. 7067-7071 5 p. |
article |
15 |
Immunity to tetanus and diphtheria in the UK in 2009
|
Wagner, Karen S. |
|
2012 |
30 |
49 |
p. 7111-7117 7 p. |
article |
16 |
Mumps: Burden of disease in France
|
Coffinières, E. |
|
2012 |
30 |
49 |
p. 7013-7018 6 p. |
article |
17 |
Neglected infectious diseases in Aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori
|
Ulanova, Marina |
|
2012 |
30 |
49 |
p. 6960-6966 7 p. |
article |
18 |
New DIVA vaccine for the protection of poultry against H5 highly pathogenic avian influenza viruses irrespective of the N-subtype
|
Peeters, Ben |
|
2012 |
30 |
49 |
p. 7078-7083 6 p. |
article |
19 |
Pertussis outbreaks and pertussis vaccines: New insights, new concerns, new recommendations?
|
Poland, Gregory A. |
|
2012 |
30 |
49 |
p. 6957-6959 3 p. |
article |
20 |
Predicting vaccination using numerical and affective risk perceptions: The case of A/H1N1 influenza
|
Renner, Britta |
|
2012 |
30 |
49 |
p. 7019-7026 8 p. |
article |
21 |
Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein
|
Wang, Wei |
|
2012 |
30 |
49 |
p. 7072-7077 6 p. |
article |
22 |
Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide
|
Chang, Janoi |
|
2012 |
30 |
49 |
p. 7090-7096 7 p. |
article |
23 |
The immunogenicity and safety of a single 0.5mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: Data from a randomized, Phase III study
|
Esposito, Susanna |
|
2012 |
30 |
49 |
p. 7005-7012 8 p. |
article |
24 |
The next generation recombinant human cytomegalovirus vaccine candidates—Beyond gB
|
Lilja, Anders E. |
|
2012 |
30 |
49 |
p. 6980-6990 11 p. |
article |
25 |
The potential economic value of a human norovirus vaccine for the United States
|
Bartsch, Sarah M. |
|
2012 |
30 |
49 |
p. 7097-7104 8 p. |
article |
26 |
The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China
|
Li, Fan |
|
2012 |
30 |
49 |
p. 7118-7122 5 p. |
article |
27 |
Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine
|
Jas, D. |
|
2012 |
30 |
49 |
p. 6991-6996 6 p. |
article |